Table 3.
Planned Preprocedure Screening of Patients for COVID-19 Before Endoscopy
| Total (n = 122) | ASC (n = 67) | Hospital-based (n = 55) | P value | |
|---|---|---|---|---|
| Which of the following approaches to screen patients for COVID-19 before endoscopy are being considered? (check all that apply) | ||||
| Symptom screen before arrival for endoscopy | 76 (62.2%) | 52 (77.6%) | 34 (50.7%) | .057 |
| Symptom screen on arrival at endoscopy laboratory | 80 (65.5%) | 50 (74.6%) | 30 (54.5%) | .02 |
| Temperature check on arrival in endoscopy laboratory | 84 (68.8%) | 54 (80.6%) | 30 (54.5%) | .002 |
| COVID-19 real-time PCR testing 2–3 days before procedure | 55 (45.1%) | 25 (37.3%) | 30 (54.5%) | .057 |
| COVID-19 real-time PCR testing on day of procedure | 7 (5.7%) | 3 (4.5%) | 4 (7.3%) | .5 |
| Serologic testing before procedure | 2 (1.6%) | 1 (1.5%) | 1 (1.8%) | .9 |
| Point-of-care testing on day of procedure | 7 (5.7%) | 3 (4.5%) | 4 (7.3%) | .28 |
| Any COVID-19 testing (PCR, serology, and/or point of care) | 60 (49.2%) | 28 (41.8%) | 32 (58.2%) | .07 |
ASC, ambulatory surgery center; PCR, polymerase chain reaction.